Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 30, 2019 9:47am

129 Views

Post# 30408553

RE:RE:RE:RE:Clinical Hold

fredgoodwinson wrote: https://www.healthlawdiagnosis.com/2018/02/fda-amends-regulations-for-data-from-foreign-and-domestic-investigations-for-medical-devices/

Think this answers my question i.e.the FDA doesn`t intend to regulate Foreign Trials.

That`s a relief anyway!

Nice!!! Just need to get through this phase 2 study in Canada with good results. Then who knows what will happen.

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023